Descriptions of pharmaceutical care provisions 2012 (BR/CU- 5056) – clarification within the framework of health insurance.
The Dutch Healthcare Authority (Nederlandse Zorgautoriteit, NZa) has approved a new ‘Descriptions of pharmaceutical care provisions’ (BR/CU-5046) policy regulation for 2012. It describes which provisions can be invoiced as pharmaceutical care on the basis of unrestricted tariffs. CVZ has assessed which of the 11 provisions included in the policy regulation can be regarded as insured pharmaceutical care.